(Q42455656)

31 October 2017

Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide (English)

1 reference

31 October 2017

N Kaushal

1

1 reference

31 October 2017

S Jain

series ordinal

2

1 reference

31 October 2017

A K Tiwary

series ordinal

3

1 reference

31 October 2017

1 March 2010

1 reference

Indian Journal of Pharmaceutical Sciences

31 October 2017

1 reference

31 October 2017

72

1 reference

31 October 2017

2

1 reference

31 October 2017

240-244

1 reference

Electrochemical determination of the antidiabetic drug repaglinide

31 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929787

Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection

16 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2929787

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20838532

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20838532

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4103/0250-474X.65029

1 reference

31 October 2017

1 reference

31 October 2017

PubMed publication ID

20838532

1 reference